- Home
- RPRX vs UMC Comparison
RPRX vs UMC Comparison
Compare RPRX & UMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- UMC
- Stock Information
- Founded
- RPRX 1996
- UMC 1980
- Country
- RPRX United States
- UMC Taiwan
- Employees
- RPRX N/A
- UMC N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- UMC Semiconductors
- Sector
- RPRX Health Care
- UMC Technology
- Exchange
- RPRX Nasdaq
- UMC Nasdaq
- Market Cap
- RPRX 16.2B
- UMC 18.0B
- IPO Year
- RPRX 2020
- UMC 2000
- Fundamental
- Price
- RPRX $39.71
- UMC $7.41
- Analyst Decision
- RPRX Strong Buy
- UMC Strong Sell
- Analyst Count
- RPRX 3
- UMC 1
- Target Price
- RPRX $46.00
- UMC N/A
- AVG Volume (30 Days)
- RPRX 4.5M
- UMC 8.5M
- Earning Date
- RPRX 11-05-2025
- UMC 10-29-2025
- Dividend Yield
- RPRX 2.21%
- UMC 5.07%
- EPS Growth
- RPRX N/A
- UMC N/A
- EPS
- RPRX 1.75
- UMC 0.10
- Revenue
- RPRX $2,349,844,000.00
- UMC $7,746,022,974.00
- Revenue This Year
- RPRX $36.16
- UMC $2.89
- Revenue Next Year
- RPRX $2.04
- UMC $6.57
- P/E Ratio
- RPRX $22.74
- UMC $13.85
- Revenue Growth
- RPRX 3.70
- UMC 4.08
- 52 Week Low
- RPRX $24.05
- UMC $5.61
- 52 Week High
- RPRX $41.24
- UMC $8.33
- Technical
- Relative Strength Index (RSI)
- RPRX 59.32
- UMC 51.84
- Support Level
- RPRX $37.31
- UMC $7.15
- Resistance Level
- RPRX $40.00
- UMC $7.45
- Average True Range (ATR)
- RPRX 1.03
- UMC 0.15
- MACD
- RPRX -0.03
- UMC 0.01
- Stochastic Oscillator
- RPRX 85.66
- UMC 88.54
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About UMC United Microelectronics Corporation (NEW)
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 5% market share in 2024 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the us, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.